Neuro-penta · Structure of the brain serotonine 5-HT3 receptor and other mammalian Cys-loop receptors
FP7 — People (Marie Curie Actions)
- Duration
- 2014-05-01 → 2018-04-30
- EU contribution
- €100,000
- Participants
- 1
- Scheme
- MC-CIG
Lines connect the coordinator with its partners.
Results in brief
Structure of the brain serotonine 5-HT3 receptor and other mammalian Cys-loop receptors
In the brain, Cys-loop receptors mediate fast neurotransmission. They function as allosteric signal transducers at the membrane of excitable cells: upon binding of neurotransmitter molecules to an extracellular site, the receptors undergo conformational transitions that result in opening of an intrinsic ion channel. The Cys-loop receptor family comprises receptors activated by serotonin, acetylcholine, glycine and GABA. Mutations in these receptors have been associated to neurological and psychiatric disorders such as epilepsy, depression and schizophrenia. In addition, mammalian Cys-loop receptors are the targets of a legion of psycho-active and therapeutic compounds (including nicotine, benzodiazepines, anti-emetics, general anesthetics). The objective of the Neuropenta project was to describe and understand, through structure, the pharmacology and conformational transitions in the Cys-loop family of receptors, focusing on the serotonin 5-HT3 receptor. Our achievements can be briefly summarized as follows: We have established the biochemical procedures to obtain large amounts of purified 5-HT3 receptor, which can then be used for crystallography and cryo-electron microscopy. We have solved the structure, by X-ray diffraction, of the serotonin 5-HT3 receptor in complex with an inhibitory nanobody. This structure shed light on the ion permeation pathway and allowed, for the first time, the description of part of the intracellular domain. We have then solved, by cryo-electron microscopy, the structures of the serotonin 5-HT3 receptor in complex with the anti-emetic drug tropisetron and in complex with serotonin. A total of four structures were obtained, which together deepen our mechanistic understanding of Cys-loop receptors at the molecular level, and also provide unprecedented detail on ligand binding. The grant had a significant impact on the career development and re-integration of the fellow. Since the award of the CIG grant, the fellow has received several competitive grants, including an important grant from the European Research Council (ERC Starting grant). He has also established collaborations with the industrial sector. The current research group of the fellow is composed of six people; it has gained local and international recognition for its expertise in membrane protein structural studies. The fellow has been regularly invited to present at international meetings, and has authored three publications as corresponding author, including one published in Nature.
Data: CORDIS, © European Union
Project objective
In the brain, fast neurotransmission involves the release of neurotransmitters in the synapse, their binding to specific receptors, which then open and let ions flow over the postsynaptic membrane. The Cys-loop receptor family directly mediates this neurotransmission.Cys-loop receptors are the targets of a legion of psycho-active and therapeutic compounds (including nicotine, alcohol, benzodiazepines, steroids, general anesthetics). More specifically, the family of -etron drugs are prominent antagonists of the 5-HT3 receptor, and widely used as anti-emetic drugs following chemotherapy or surgery. Therefore, the investigation into the structural mechanisms of these receptors can provide both fundamental biological insights and potential benefits to health.The project proposes to describe and understand, through structure, the pharmacology and conformational transitions in the Cys-loop family of receptors, focusing first on the serotonin 5-HT3 receptor.Starting with a solid body of preliminary results, we will first set up new expression and stabilization tools to facilitate structural studies. Then we will obtain high-resolution structures of the 5-HT3 receptor and of other mammalian receptors, taking advantage of crystallization chaperones. On the way, we will also investigate and engineer proteinic modulators of Cys-loop receptor function.The proposed research will take place at the CNRS in Grenoble, France, in a very favorable environment for structural biology. The applicant is establishing his own group and bringing a new research theme to the host institute. The CIG grant will be instrumental in the success of the proposed research and in the career development of the applicant.
Original text from CORDIS.
Participants
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS · ParisCoordinatorFrance
Links
Data: CORDIS, © European Union
